Biotech Ideas

[gfp927z]

Acurx -- a summary slide of the various CDI trial results of the various antibiotics (below). Two are Phase 3 results, and one is from a Phase 2. In the Phase 2 (33 patients), the Vancomycin initial cure rate was 70%. Compare that to Acurx's Phase 2, where Vancomycin had a 100% initial cure rate. So it demonstrates just how limited the validity of all data is from a small Phase 2 -







---